1. Addolorato, G., Armuzzi, A., Gasbarrini, G., De Lorenzi, G., Ancona, C., Abenavoli, L., et al. (2002). Pharmacological approaches to the management of alcohol addiction. European Review for Medical and Pharmacological Sciences, 6, 89–97.
2. Agabio, R., Preti, A., & Gessa, G. L. (2013). Efficacy and tolerability of baclofen in substance use disorders: A systematic review. European Addiction Research, 19, 325–345.
3. Agmo, A., Pruneda, R., Guzman, M., & Gutierrez, M. (1991). GABAergic drugs and conflict behavior in the rat: Lack of similarities with the actions of benzodiazepines. Naunyn-Schmiedeberg's Archives of Pharmacology, 344, 314–322.
4. Aley, K. O., & Kulkarni, S. K. (1989). GABA-mediated modification of despair behavior in mice. Naunyn-Schmiedeberg's Archives of Pharmacology, 339, 306–311.
5. Aley, K. O., & Kulkarni, S. K. (1990). Effect of baclofen, a GABAB-agonist, on forced swimming-induced immobility in mice. Archives Internationales de Pharmacodynamie et de Thérapie, 307, 18–31.